Better is Faster

Trust Aerogen Ultra to deliver a new standard of respiratory patient care.

Compared to a jet nebuliser the Aerogen Ultra delivers significantly more medication in half the time
with improved patient response², reducing hospital admissions from the ED³.


High performance aerosol drug delivery

  • Aerogen Ultra delivers significantly more medication in half the time1.
  • Improves patient response to treatment2
  • Works with and without O25
  • Can be used with a mask or mouthpiece5





Superior Performance across multiple modalities

Aerogen Solo provides superior treatment over the entire care continuum for ventilated and non-ventilated patients.

Aerogen in the Emergency Department

Clinical outcome data demonstrates how Aerogen Ultra is transforming the treatment of patients in the Emergency Department.


WATCH: Dr Dunne talks about Aerogen Ultra’s success in the ED

Study Design
A retrospective chart review of 1,594 patients at St. John Hospital and Medical Center, Detroit (USA) compared clinical outcomes associated with the use of a hospital standard jet nebuliser versus the Aerogen Ultra.
37min

median reduction in ED length of stay

32%

reduction in admission rates

85%

of patients achieving symptom control with one 2.5mg salbutamol dose


30%

higher discharge rates


Download Paper

Improved Patient Response to Treatment

Borg Breathlessness scores improved significantly only with the Aerogen Ultra

Improved patient response to treatment with a single 2.5mg salbutamol dose with Aerogen Ultra in comparison to a jet nebuliser:
–Significantly greater improvement in FVC
–Clinically significant improvements in IC (>10% increase), RV (>0.3L reduction)
Patient feels better with vibrating mesh Aerogen Ultra
–Exacerbation recovery is associated with increases in respirable lung volume 6

Borg Symptom score

Aerogen Ultra delivers 6X greater lung dose*

Aerogen Ultra

Jet Nebuliser

Lung dose delivered: Aerogen Ultra 34.1%; Jet Nebuliser 5.2% (p < 0.001) Residual dose volume: Aerogen Ultra 2.4%; Jet Nebuliser 62.8% (p = 0.008)

Nebulisers were filled with diethylenetriaminepentaacetic acid labelled with
technetium-99 m (99mTc-DTPA, 2 mCi/4 mL) Dugernier J. et al 20174

*Aerogen Ultra compared to a standard Jet Nebuliser.

Download the paper

Aerogen Ultra delivers significantly more medication in half the time

Hickin et al. Poster at the College of Emergency Medicine Clinical Excellence Conference 2014

Trusted by the world's leading ventilation manufacturers

 

 

Quisque cursus in nunc in vulputate
Phasellus tempus vulputate auctor
Download Aerogen ED Brochure

References

1. Hickin S, Mac Loughlin R, Sweeney L, Tatham A and Gidwani S. Comparison of mesh nebuliser versus jet nebuliser in simulated adults with chronic obstructive pulmonary disease. Poster at the College of Emergency Medicine Clinical Excellence Conference. 2014. 2. Cushen B, et al. BTS poster presentation. 2016 3. Dunne RB and Shortt S. Comparison of bronchodilator administration with vibrating mesh nebulizer and standard jet nebulizer in the emergency department. The American journal of emergency medicine. 2017. 4. Dugernier et al. SPECTCT Comparison of Lung Deposition using a System combining a Vibrating-mesh Nebulizer with a Valved Holding Chamber and a Conventional Jet Nebulizer: a Randomized Cross-over Study. Pharm Res. 2016 Nov 7 (epub). 5. Aerogen Solo Instruction Manual.